Pages
Products

Inactivated Wild-Type Human Coronavirus (229E)

For research use only. Not intended for any clinical use.

Cat. No. :   VNV-115

Inquire for Price

Virus Particles Information

Cat. No. VNV-115
Description Wild type human coronaviruses (strain 229E) which are inactivated by heat treatment. This product is intended for research use only.
Storage -80°C
Shipping Dry ice
Quick Inquiry

Background

Case Study

Q & A

Customer Reviews

Human coronavirus 229E (HCoV-229E) is one of seven known human coronaviruses, primarily causing mild upper respiratory tract infections such as the common cold. The virus is transmitted through respiratory droplets, direct contact with infected individuals, or fomites (contaminated surfaces). The virus enters the host through the nasal or oral mucosa, targeting epithelial cells in the upper respiratory tract. Following infection, HCoV-229E binds to the host cell receptor human aminopeptidase N (hAPN or CD13), facilitating viral entry and replication. The incubation period is 2 to 5 days, after which symptoms such as runny nose, sore throat, cough, and occasionally fever may develop. While the infection is generally self-limited, patients with compromised immune systems or pre-existing respiratory conditions may develop severe complications such as pneumonia or bronchitis.

HCoV-229E belongs to the genus Alphacoronavirus in the Coronaviridae family. Like all coronaviruses, it is an enveloped, positive-sense, single-stranded RNA (+ssRNA) virus with a characteristic spherical morphology and a prominent spike (S) glycoprotein protruding from its surface. The viral envelope also contains membrane (M) and envelope (E) proteins, which play key roles in viral assembly and egress. The nucleocapsid (N) protein binds to the RNA genome to form the helical nucleocapsid. The HCoV-229E genome is approximately 27.3 kilobase pairs in length, making it one of the largest RNA viruses. It encodes nonstructural proteins involved in RNA synthesis (such as the replicase polyprotein) and structural proteins (S, M, E, and N) essential for virion formation. The 5′ end of the genome contains a leader sequence and untranslated regions (UTRs) essential for replication, while the 3′ end contains a poly-A tail. The S protein mediates receptor binding and membrane fusion, determining host tropism and pathogenicity. Due to its high mutation rate, HCoV-229E has strong genetic variability, which enables it to evade immune responses and persist in the population.

To gain a deeper understanding of the signaling and molecular events that orchestrate the overall host response within the nucleus of coronavirus-infected cells, researchers investigated transcriptome dynamics in A549 and HuH7 cells infected with human coronavirus 229E (HCoV-229E), respectively, revealing a core signature of upregulated genes in these cells. Compared with treatment with the canonical inflammatory cytokine interleukin (IL)-1, HCoV-229E replication was found to attenuate the induction of transcription factor (TF) NF-κB and limit the nuclear concentration of NF-κB subunits through (i) an unusual mechanism involving partial degradation of IKKβ, NEMO, and IκBα, and (ii) upregulation of TNFAIP3 (A20), although constitutive IKK activity and basal TNFAIP3 expression levels have been shown to be required for efficient viral replication. The data showed that a large number of genes were activated in cells infected with HCoV (but not treated with IL-1), while the inducible p65 NF-κB was not recruited. Both HCoV-229E replication and IL-1 were shown to upregulate a small set of genes encoding immune regulators that bind p65 at their promoters and require IKKβ activity and p65 for expression. In addition, HCoV-229E and IL-1 activated a common set of 440 p65-binding enhancers that differed from an additional 992 HCoV-229E-specific enhancer regions by their combination of TF binding motifs. Taken together, this study demonstrates that cytoplasmic RNA viruses fine-tune NF-κB signaling at multiple levels and deeply reprogram host cell chromatin architecture to orchestrate the timely and coordinated expression of genes involved in multiple signaling, immunoregulatory and metabolic processes.

To systematically analyze the host cell gene response induced by HCoV-229E, the researchers first performed a series of whole transcriptome studies using the A549 lung epithelial cancer cell model. To detect transcriptional changes caused by viral replication, cells were infected with low multiplicity (replication-competent) HCoV-229E (MOI 0.001) or inoculated with replication-incompetent (heat- or UV-inactivated) HCoV-229E. At 16 and 48 hours post-infection (p.i.), increasing amounts of HCoV-229E RNA were detected in HCoV-229E-infected cells, but not in control cells inoculated with heat- or UV-inactivated HCoV-229E. Transcriptome analysis revealed that HCoV-229E infection resulted in differential expression of 108 genes at 16 hours post-infection and 239 genes at 48 hours post-infection (Figure 1A, top). An almost identical set of differentially expressed genes was also found in control cells inoculated with heat-inactivated virus (i.e., virus did not replicate) (Figure 1A, lower left and middle panels), suggesting that the observed differential gene expression was largely due to soluble factors present in the virus stock or interactions between cells and non-infectious virus particles. However, after 2 days of infection, a specific set of 26 up-regulated genes and 11 down-regulated genes were also identified that were differentially regulated only in cells infected with replication-competent HCoV-229E but not in cells inoculated with inactivated virus (Figure 1A, lower right panel).

A549 lung epithelial cells were infected with HCoV-229E and collected for further analyses at 16, 24 and 48 h p.i.. As controls, cells were mock-infected or incubated with heat-inactivated HCoV-229E and collected at the time points indicated above.Figure 1. A549 lung epithelial cells were infected with HCoV-229E and collected for further analyses at 16, 24 and 48 h p.i.. As controls, cells were mock-infected or incubated with heat-inactivated HCoV-229E and collected at the time points indicated above. (Poppe M, et al., 2017)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Excellent product!

Creative Biogene's product exceeded expectations. The inactivation was thorough, ensuring lab safety, while the antigenicity remained intact, allowing us to achieve high sensitivity and specificity in our assays. A dependable standard for coronavirus diagnostic development.

United Kingdom

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction